Article Versions Notes

Carles M, Fechter T, Grosu AL, Sörensen A, Thomann B, Stoian RG, Wiedenmann N, Rühle A, Zamboglou C, Ruf J, et al. ¹⁸F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy. Cancers. 2021; 13(14):3449. https://doi.org/10.3390/cancers13143449

Carles, Montserrat, Tobias Fechter, Anca L. Grosu, Arnd Sörensen, Benedikt Thomann, Raluca G. Stoian, Nicole Wiedenmann, Alexander Rühle, Constantinos Zamboglou, Juri Ruf, and et al. 2021. "¹⁸F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy" Cancers 13, no. 14: 3449. https://doi.org/10.3390/cancers13143449

Carles, M., Fechter, T., Grosu, A. L., Sörensen, A., Thomann, B., Stoian, R. G., Wiedenmann, N., Rühle, A., Zamboglou, C., Ruf, J., Martí-Bonmatí, L., Baltas, D., Mix, M., & Nicolay, N. H. (2021). ¹⁸F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy. Cancers, 13(14), 3449. https://doi.org/10.3390/cancers13143449